Butyrate

Dual role of microbiota-derived short-chain fatty acids on host and pathogen

Butyrate, Gut Microbiota, Parkinson's Disease, Pre-PD, Short Chain Fatty Acids /

A growing body of documents shows microbiota produce metabolites such as short-chain fatty acids (SCFAs) as crucial executors of diet-based microbial influence the host and bacterial pathogens. The production of SCFAs depends on the metabolic activity of intestinal microflora and is also affected by dietary changes. SCFAs play important roles in maintaining colonic health as […]

Dual role of microbiota-derived short-chain fatty acids on host and pathogen Read More »

The Role of Dysbiosis in Neurological Disorders

Biomarkers, Butyrate, Fecal Transplants (FMT), Gut Dysbiosis, Gut Microbiota, Gut Permeability / Leaky Gut, Gut-Brain axis, Metabolites, Parkinson's Disease, Pre-PD, Probiotics, Prebiotics and Symbiotics, Short Chain Fatty Acids /

The gut brain axis is a system of bi-directional communication. When the delicate balance of the microbiome is disrupted, the resulting dysbiosis can be a factor in the development of neurological disorders, including Alzheimer’s Disease (AD), Parkinson’s Disease (PK), and Multiple Sclerosis (MS). One major player in the gut brain axis are short-chain fatty acids

The Role of Dysbiosis in Neurological Disorders Read More »

Short-chain fatty acids as modulators of redox signaling in health and disease

Butyrate, Probiotics, Prebiotics and Symbiotics, Short Chain Fatty Acids /

Short-chain fatty acids (SCFAs), produced by colonic bacteria and obtained from the diet, have been linked to beneficial effects on human health associated with their metabolic and signaling properties. Their physiological functions are related to their aliphatic tail length and dependent on the activation of specific membrane receptors. In this review, we focus on the mechanisms underlying

Short-chain fatty acids as modulators of redox signaling in health and disease Read More »

Microbiota in Health and Disease—Potential Clinical Applications

A-Synuclein, Butyrate, Diet and Exercise, Gut Microbiota, Gut-Brain axis, Parkinson's Disease, Pre-PD, Short Chain Fatty Acids, Vagal Nerve /

: Within the last two decades tremendous efforts in biomedicine have been undertaken tounderstand the interplay of commensal bacteria living in and on our human body with our ownhuman physiology. It became clear that (1) a high diversity especially of the microbial communitiesin the gut are important to preserve health and that (2) certain bacteria

Microbiota in Health and Disease—Potential Clinical Applications Read More »

Treating chronic diseases by regulating the gut microbiota

Butyrate, Diet and Exercise, Gut Dysbiosis, Gut Microbiota, Short Chain Fatty Acids, Vitamins / Supplements / Nutraceuticals /

Chronic diseases encompass a wide range of illnesses, ranging from cardiovascular and cerebrovascular diseases, metabolic syndromes to degenerative neurological disorders. Chronic diseases are responsible for most observed morbidity and mortality in the developed countries as well as in some developing countries. The gut microbiota and its metabolites have been associated with the onset and development

Treating chronic diseases by regulating the gut microbiota Read More »

Gut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion

Butyrate, Gut Dysbiosis, Gut Microbiota, Short Chain Fatty Acids /

Emerging evidence is revealing that alterations in gut microbiota are associated with colorectal cancer (CRC). However, very little is currently known about whether and how gut microbiota alterations are causally associated with CRC development. Here we show that 12 faecal bacterial taxa are enriched in CRC patients in two independent cohort studies. Among them, 2 Porphyromonas species

Gut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion Read More »

The effect of oral butyrate administration on the release of serotonin and dopamine in the gastrointestinal trac

Butyrate, Gut Microbiota, Gut-Brain axis /

The microbiota-gut-brain axis is a modern concept with wide and physiologically important effects.The aim of the study was to investigate if an orally given short chain fatty acid (SCFA), butyrate,stimulates the formation and release of serotonin and dopamine in an in vivo rat model. The effect ofbutyrate was investigated in the entire gastrointestinal tract since

The effect of oral butyrate administration on the release of serotonin and dopamine in the gastrointestinal trac Read More »

Parkinson’s disease patients’ short chain fatty acids production capacity after in vitro fecal fiber fermentation

Butyrate, Diet and Exercise, Gut Permeability / Leaky Gut, Parkinson's Disease, Probiotics, Prebiotics and Symbiotics, Short Chain Fatty Acids /

Short-chain fatty acid production was analyzed by headspace solid-phase micro-extraction gas chromatography-mass spectrometry. Clostridium coccoides and C. leptum were quantified through 16S-rRNA gene-targeted group-specific qPCR. Factors influencing short-chain fatty acid production were investigated using linear mixed models. After fiber fermentation, butyrate concentration varied between 25.6 ± 16.5 µmol/g and 203.8 ± 91.9 µmol/g for Parkinson’s patients and between 52.7 ± 13.0 µmol/g and 229.5 ± 42.8 µmol/g for controls. Inulin had

Parkinson’s disease patients’ short chain fatty acids production capacity after in vitro fecal fiber fermentation Read More »

Comparing the Results from Faecal Microbiome Transplantation (Fmt) and Gut Flora Replacement Therapy (Gfrt) using 16s Mrna Microbiome Mappin

Butyrate, Fecal Transplants (FMT), Parkinson's Disease /

We used the data from 10 randomly chosen patients from our cohort of FMT patients and the same for 10 randomly chosenpatients who had received GFRT. We measured their microbiomes using 16S mRNA tests, the results are shown in Tables 3 and 4. The reference values for the laboratory were used for these tests are

Comparing the Results from Faecal Microbiome Transplantation (Fmt) and Gut Flora Replacement Therapy (Gfrt) using 16s Mrna Microbiome Mappin Read More »

Influence of probiotic bacteria on gut microbiota composition and gut wall function in an in-vitro model in patients with Parkinson’s disease

Butyrate, Gut Dysbiosis, Gut Permeability / Leaky Gut, Pre-PD, Probiotics, Prebiotics and Symbiotics, Short Chain Fatty Acids /

In general, the relative proportions of the main bacterial phyla in the microbiotas of PD patients differed from those of healthy subjects, with levels of Firmicutes raised and levels of Bacteroidetes reduced. Dosing with probiotic resulted in a change in bacterial composition in the microbiotas over a 48 h period. Several other indicators of gut health changed upon dosing with

Influence of probiotic bacteria on gut microbiota composition and gut wall function in an in-vitro model in patients with Parkinson’s disease Read More »